HealthEquity Stock Climbs After Q2 Earnings Report: Here's Why

Core Insights - HealthEquity reported adjusted earnings of $1.08 per share, exceeding the Street estimate of 92 cents [1] - Quarterly revenue reached $325.83 million, surpassing the analyst estimate of $320.82 million [1] - The company experienced a 9% revenue growth, a record gross margin of 71%, and a record adjusted EBITDA of $151 million [2] Outlook and Guidance - HealthEquity raised its fiscal 2026 adjusted EPS guidance to a range of $3.74 to $3.91, compared to the previous estimate of $3.72 [3] - The fiscal 2026 revenue guidance was also increased to between $1.29 billion and $1.31 billion, against the prior estimate of $1.3 billion [3] Key Metrics - The company reported 10.0 million Health Savings Accounts (HSAs), a 6% increase compared to the second quarter of FY25 [5] - Total HSA assets amounted to $33.1 billion, reflecting a 12% increase from the second quarter of FY25 [5] - The total number of accounts, including HSAs and complementary Consumer Directed Benefits (CDBs), reached 17.1 million, a 5% increase compared to the second quarter of FY25 [5]